Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

Other cookies are those that are being identified and have not been classified into any category as yet.

Salvatore Piscuoglio

Associate Professor

Genetics
Associate Professor

Education

Salvatore Piscuoglio obtained his degree in Medical Biotechnology at the University of Naples “Federico II” in 2008. He obtained his PhD in Genetics at the University of Basel (CH) in 2012.  After completing his studies, he joined the Memorial Sloan Kettering Cancer Center (NY, USA) as a postdoctoral researcher in 2013, where he worked on the characterization of human cancers using omics technologies for the discovery new biomarkers and therapeutic targets and the elucidation of genotype-to-phenotype associations. After the completion of his postdoctoral training, in 2016, he became a group leader at the Institute of Medical Genetics and Pathology at the University Hospital Basel and in 2019 group leader at the Department of Biomedicine, University of Basel (CH) and co-director of research at the Institute of Medical Genetics and Pathology at the University Hospital Basel. He joined Humanitas as Associate Professor of Genetics in 2024.

HUMANITAS GROUP

Humanitas is a highly specialized Hospital, Research and Teaching Center. Built around centers for the prevention and treatment of cancer, cardiovascular, neurological and orthopedic disease – together with an Ophthalmic Center and a Fertility Center – Humanitas also operates a highly specialised Emergency Department.